Evaluate the Efficacy of MEDI4736 in Immunological Subsets of Advanced Colorectal Cancer

Patients will be seen the day of administration of MEDI4736. A medical history, with particular reference to toxicities, including medication review, and physical examination will be conducted at each treatment visit.